How does the age of a blood sample affect it's activated clotting time? Comparison of eight different devices

Journal of Extra-Corporeal Technology

Volumn 34, Issue 3, 2002, Pages 175-177

  Searles, Bruce ^a   Nasrallah, Fadi ^a   Darling, Edward ^a   Yarcusko, Sarah ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Accuracy; ACT; Activated clotting time; Cardiopulmonary bypass; Heparin

Indexed keywords

ACCURACY; ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; HEPARINIZATION; HUMAN; TIME;

EID: 0036745012     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Shore-Lessersom L, Gravlee GP. Anticoagulation for cardiopulmonary bypass. In: Cardiopulmonary Bypass, 2nd ed. Gravlee GP, Davis RF, Kurusz M, Utley JR, eds. Philadelphia: Lippincott Williams & Wilkins, 2000: 435-72.
2. Cohen JA. Activated coagulation time method for control of heparin is reliable during cardiopulmonary bypass. Anesthesiology. 1984;60:121-4.
3. Hattersley PG. Activated coagulation time of whole blood. JAMA. 1966;196:436-40.
4. Hemochron Whole Blood Coagulation System, package insert. International Technidyne Corporation; May, 1999.
5. Sonoclot Coagulation & Platelet Function Analyzer Operator's Manual; SonACT Kit #800-0432(100s), #800-0431(24s), package insert. Sienco, Inc. November, 1998.
6. Cohen EJ, Camerlengo LJ, Dearing JP. Activated clotting times and cardiopulmonary bypass I: The effect of hemodilution and hypothermia upon activated clotting time. J Extra Corp Tech. 1980;12:139-41.
7. Kase PB, Dearing JP. Factors affecting the activated clotting time. JECT. 1985:17:27-30.